Company intelligence / Profile preview

Korea Ginseng Corporation

Ownership: Private
Development stage: Commercial

Overview

KGC produces Korean Red Ginseng products under the brand name 'Cheong Kwan Jang' with a dominant market share of over 80% in the Korean ginseng market and 35% of Korea's total health products market as of 2011

Therapeutic areas: OtherDermatology
Modalities: Natural productsRed ginseng extracts
Industry: Food & Nutrition

Drug pipeline

2 assets

YPD-HAT

Pre-clinical

Indications: Parkinson's disease

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Korea Ginseng Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Korea Ginseng Corporation.

Explore the full profile